Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Robert L Burton"'
Autor:
Kristen Feemster, William P. Hausdorff, Natalie Banniettis, Heather Platt, Priscilla Velentgas, Alejandra Esteves-Jaramillo, Robert L. Burton, Moon H. Nahm, Ulrike K. Buchwald
Publikováno v:
Vaccines, Vol 12, Iss 9, p 974 (2024)
Pneumococcal vaccines are a cornerstone for the prevention of pneumococcal diseases, reducing morbidity and mortality in children and adults worldwide. Pneumococcal vaccine composition is based on the polysaccharide capsule of Streptococcus pneumonia
Externí odkaz:
https://doaj.org/article/df5b5512f0a1450c8b212eea935fbaaf
Autor:
Yaru Shi, Katrina M. Nolan, Robert L. Burton, Tulin Shekar, Rocio D. Murphy, Natalie Banniettis, Luwy Musey, Ulrike K. Buchwald
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 2 (2023)
Pneumococcal serogroups consist of structurally related serotypes, and serotype-specific antibodies can cross-react against other serotypes within the same serogroup. Cross-reactivity of vaccine-induced serotype 6A antibodies, and, to a lesser extent
Externí odkaz:
https://doaj.org/article/67c29386504f4f9c9be3b03037d0927c
Autor:
Yaru Shi, Katrina Nolan, Robert L Burton, Rocio Murphy, Natalie Banniettis, Luwy Musey, Ulrike Buchwald
Publikováno v:
JAC-Antimicrobial Resistance. 5
Background Pneumococcal serotype 6C has structural similarity with serotype 6A and, to a lesser degree, serotype 6B. The 13-valent PCV (PCV13), which contains serotypes 6A and 6B, induces cross-reactive opsonophagocytic killing activity (OPA) antibod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3eee1f9dd755262bfaa78118dc4f9b82
https://doi.org/10.1093/jacamr/dlac133.010
https://doi.org/10.1093/jacamr/dlac133.010
Autor:
Harry W. Schroeder, Robert L. Burton, A. Krishna Prasad, Andrew O. Westfall, Anju Bansal, Annaliesa S. Anderson, Suddham Singh, Gregory C. Ippolito, Michael W. Pride, Binghao J. Peng, Sarah Sterrett, Paul A. Goepfert, David C. LaFon, Moon H. Nahm
Publikováno v:
Vaccine
Background PCV13 (conjugated polysaccharide) and PPSV23 (polysaccharide only) are two licensed vaccines targeting S. pneumoniae. The role of CD4 T-cell responses in pneumococcal vaccines among healthy participants and their impact on antibodies is no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9d1ba67babf6c743e70c9da4cafa5f8
https://doi.org/10.1016/j.vaccine.2019.12.023
https://doi.org/10.1016/j.vaccine.2019.12.023
Publikováno v:
J Clin Immunol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb3f87a2f78c23d0ddb36cce350b0d33
https://europepmc.org/articles/PMC8605991/
https://europepmc.org/articles/PMC8605991/
Autor:
Han Wool Kim, Robert L. Burton, Hun Kim, Kyung Hyo Kim, Julie M. Skinner, Kun Young Ku, Sun Jin Kim, Moon H. Nahm, Jihye Seo, Seuk Keun Choi, Soyoung Lee, Jee hyun Seok, Jinfu Xie, Yeong Ok Baik, Sejong Bae, Debra Mcguinness
Publikováno v:
Vaccine
Pneumococcal conjugate vaccines (PCVs) have been effective in reducing the disease burden caused by Streptococcus pneumoniae. The first licensed PCV (PCV7) was composed of capsular polysaccharides from seven serotypes. This was followed by PCV10, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c9c1e6f57e721400e120979abefc6e7
https://pubmed.ncbi.nlm.nih.gov/33162203
https://pubmed.ncbi.nlm.nih.gov/33162203
Autor:
Nadine Rouphael, Kathryn M. Edwards, Robert L. Burton, Hana M. El Sahly, Mark J. Mulligan, Moon H. Nahm, Aya Nakamura, Lisa A. Jackson, Rebecca C. Brady, Wendy A. Keitel, Jennifer Ferreria, Sarah L. George, Patricia L. Winokur
Publikováno v:
Vaccine. 36:606-614
Introduction In older adults, prior administration of 23-valent pneumococcal polysaccharide vaccine (PPSV23) blunts the opsonophagocytic antibody (OPA) response to subsequent administration of 13-valent pneumococcal conjugate vaccine (PCV13). To dete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f13088a9a0d9528558ebe54a0d55ee72
https://doi.org/10.1016/j.vaccine.2017.12.061
https://doi.org/10.1016/j.vaccine.2017.12.061
Publikováno v:
Journal of Clinical Microbiology. 54:967-971
Genetic studies of serogroup 6 isolates of Streptococcus pneumoniae identified putative serotype 6E. Although its capsular polysaccharide structure has not been elucidated, putative serotype 6E is described in an increasing number of studies as a pot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5586dc50c70f18dfc820a598da8f72e
https://doi.org/10.1128/jcm.03194-15
https://doi.org/10.1128/jcm.03194-15
Autor:
Dominique Wauters, Ki-Hyun Kim, David Goldblatt, G. L. Xie, Robert L. Burton, David A. Cooper, Moon H. Nahm, Mustafa Akkoyunlu, F. Williams, Lucy Roalfe, Brian D. Plikaytis, Joseph M. Antonello
Publikováno v:
Clinical and Vaccine Immunology. 24
Opsonophagocytic assays (OPAs) are routinely used for assessing the immunogenicity of pneumococcal vaccines, with OPA data often being utilized for licensure of new vaccine formulations. However, no reference serum for pneumococcal OPAs is available,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ca25db66daa569c3d01c41282093625
https://doi.org/10.1128/cvi.00457-16
https://doi.org/10.1128/cvi.00457-16
Autor:
Patricia N. Coan, Moon H. Nahm, Kyung Hyo Kim, Dong Kwon Rhee, Shaper Mirza, Janice King, Yvette Hale, Calvin C Daniels, Melissa Walker, Robert L. Burton, David E. Briles
Publikováno v:
Clinical and Vaccine Immunology. 20:1549-1558
The standard opsonophagocytosis killing assay (OPKA) for antibodies to pneumococcal capsular polysaccharide was modified to permit an evaluation of the protection-mediating antibodies to pneumococcal surface protein A (PspA). We found that by increas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09a13e00d222b8e887df5d78e6a0fa8b
https://doi.org/10.1128/cvi.00371-13
https://doi.org/10.1128/cvi.00371-13